Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data
Novo Nordisk A/S
Novo Nordisk A/S
Rutgers, The State University of New Jersey
Korea University Anam Hospital
University of Pecs
Postgraduate Institute of Dental Sciences Rohtak
Ministry of Health, Saudi Arabia
Boston VA Research Institute, Inc.
Qianfoshan Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Antea Foundation
Centre Hospitalier Universitaire de la Guadeloupe
Rambam Health Care Campus
University of Vienna
Southern Cross Fertility Centre
Nagaoka Red Cross Hospital
Xiamen University
Taipei Veterans General Hospital, Taiwan
Odense University Hospital